Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImmupharma Share News (IMM)

Share Price Information for Immupharma (IMM)

Share Price is delayed by 15 minutes
Get Live Data
4.40    -0.41 (-8.52%)
Bid:
4.40
Ask:
4.50
Spread: 0.10 (2.273%)
Market Cap: £27.45m
IMM Live PriceLast checked at - London Stock Exchange

Intraday Immupharma Share Chart

Immupharma News

IN BRIEF: ImmuPharma appoints COO Tim Franklin to board of directors
16 Jul 2021

IN BRIEF: ImmuPharma appoints COO Tim Franklin to board of directors

IN BRIEF: ImmuPharma appoints COO Tim Franklin to board of directors

AIM WINNERS & LOSERS: Pantheon up on resource upgrade, farmout talks
16 Jul 2021

AIM WINNERS & LOSERS: Pantheon up on resource upgrade, farmout talks

AIM WINNERS & LOSERS: Pantheon up on resource upgrade, farmout talks

IN BRIEF: Immupharma moves step closer to Lupazor phase three trial
24 Jun 2021

IN BRIEF: Immupharma moves step closer to Lupazor phase three trial

IN BRIEF: Immupharma moves step closer to Lupazor phase three trial

UK shareholder meetings calendar - next 7 days
21 Jun 2021

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

EXECUTIVE CHANGES: Gresham House Strategic plots future as chair exits
24 May 2021

EXECUTIVE CHANGES: Gresham House Strategic plots future as chair exits

EXECUTIVE CHANGES: Gresham House Strategic plots future as chair exits

TRADING UPDATES: Keystone Law and Checkit post annual revenue growth
29 Apr 2021

TRADING UPDATES: Keystone Law and Checkit post annual revenue growth

TRADING UPDATES: Keystone Law and Checkit post annual revenue growth

ImmuPharma clarifies next steps for phase 3 Lupuzor trial
9 Feb 2021

ImmuPharma clarifies next steps for phase 3 Lupuzor trial

(Sharecast News) - Specialist drug discovery and development company ImmuPharma updated the market on the new optimised international phase 3 trial of...

AIM WINNERS & LOSERS: Tavistock Rises As Tips Annual Earnings Climb
9 Feb 2021

AIM WINNERS & LOSERS: Tavistock Rises As Tips Annual Earnings Climb

AIM WINNERS & LOSERS: Tavistock Rises As Tips Annual Earnings Climb